Encision, Inc. · OTC:ECIA

Encision — Investor Presentation (April 2019)

9 slides from Encision's investor presentation, Apr 1, 2019

  1. Slide 1: Encision Inc.

    ENCISION Inc. Boulder, Colorado OTC: ECIA Eliminating deadly stray energy in Laparoscopic Surgery with proprietary high performance surgical instrument system.

  2. Slide 2: Encision Inc. Disclaimer Statement

    Encision Inc. Disclaimer Statement The following information does not purport to be all-inclusive or to contain all the information that you may desire for investing in Encision. You should conduct and rely on your own evaluation of Encision, including the merits and risks involved, in making an inv

  3. Slide 3: Strong Need for Encision's AEM Technology

    Strong Need for Encision’s AEM® Technology • Approximately 8 million standard laparoscopic surgical procedures in the US in 2018. ~85% use Monopolar Surgical Energy to dissect tissues and create hemostasis. • Stray Energy during Laparoscopic Surgical procedures kills 400-500 patients each year in th

  4. Slide 4: Forms of Stray Energy in Laparoscopy

    Forms of Stray Energy in Laparoscopy Insulation Failure Capacitive Coupling Active Electrosurgical Electrode Active Electrosurgical Electrode Failure Rate: Between 400-500 Patients die 1 in 5 – Reusables each year from stray energy burns 1 in 33 – Disposables (Fecal Peritonitis Post Operative Sepsis

  5. Slide 5: Delivering Value

    Delivering Value Dangerous Stray Energy Clinical Value: AEM® Technology alone saves patient lives by eliminating stray energy burns during laparoscopy. Economic Value: AEM® Technology alone reduces hospital liability by eliminating a source of surgical malpractice, reduces hospital risk of CMS penal

  6. Slide 6: Where have we been?

    Where have we been? Phase I - Turn Around • Operational Excellence • Aggressive Cost Cutting • Process Optimization • Driving New Efficiencies • Bolstering the Product Portfolio and Sales Channel • EM100 monitor quickly iterated to EM200 • New ES5107 Cable • New EM3 Capital Monitor • Re-Established

  7. Slide 7: Where do we go from here?

    Where do we go from here? Phase II - Drive Increased revenues from portfolio enhancements and increased sales presence. Opportunities: • New products for existing call points • Iterate existing products for cost and aesthetic improvement • Optimize US Channel and expand International Sales • License

  8. Slide 8: Encision LT Vision

    Encision LT Vision 10-15% Annual Growth Objective • Increased Customer Awareness • New AEM® Product Development • US Channel Optimization • OUS Channel Expansion

  9. Slide 9: Thank You!

    Thank You! Encision • Life Saving Technology • Gaining traction in the market • Operational excellence • Driving revenues and profitability • An attractive opportunity Symbol: ECIA www.encision.com

Encision — Investor Presentation (April 2019) on 6ix